Ibex Investors LLC Halozyme Therapeutics, Inc. Transaction History

Ibex Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$17.06 - $21.2 $217,327 - $270,066	-12,739 Closed	0 $0
Q4 2017 Feb 27, 2019	SELL	$16.75 - $20.8 $2,747 - $3,411	-164 Reduced 1.27%	12,739 $261,000
Q4 2017 Nov 21, 2018	BUY	$16.75 - $20.8 $2,747 - $3,411	164 Added 1.29%	12,903 $261,000
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $213,378 - $264,971	12,739	12,739 $258,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.36B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Ibex Investors LLC with notifications on news.